Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial.

Saved in:
Bibliographic Details
Title: Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial.
Authors: Kang J; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea., Park S; Department of Cardiovascular Medicine, Boramae Medical Center, Seoul, South Korea., Yang HM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea., Shin ES; Department of Cardiovascular Medicine, Ulsan University Hospital, Ulsan, South Korea., Rha SW; Department of Cardiovascular Medicine, Korea University Guro Hospital, Seoul, South Korea., Bae JW; Department of Cardiovascular Medicine, Good SamSun Hospital, Busan, South Korea., Lee NH; Department of Cardiovascular Medicine, Kangnam Sacred Heart Hospital, Hallym University, Seoul, South Korea., Yoon HJ; Department of Cardiovascular Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea., Cho YH; Department of Cardiovascular Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, South Korea., Kim U; Department of Cardiovascular Medicine, Yeungnam University Medical Center, Daegu, South Korea., Kim SY; Department of Cardiovascular Medicine, Jeju National University Hospital, Jeju, South Korea., Kim SH; Department of Cardiovascular Medicine, Boramae Medical Center, Seoul, South Korea., Han JK; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea., Park KW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea. Electronic address: kwparkmd@snu.ac.kr., Kim HS; Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea. Electronic address: hyosoo@snu.ac.kr.
Corporate Authors: HOST-EXAM investigators
Source: Lancet (London, England) [Lancet] 2026 Apr 11; Vol. 407 (10537), pp. 1439-1447. Date of Electronic Publication: 2026 Mar 29.
Publication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-547X
DOI:10.1016/S0140-6736(26)00422-8